<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3411054/" ref="ordinalpos=1834&amp;ncbi_uid=5161752&amp;link_uid=PMC3411054" image-link="/pmc/articles/PMC3411054/figure/F6/" class="imagepopup">FIGURE 6. From: Targeting the Sonic Hedgehog <span class="highlight" style="background-color:">Pathway</span> in Keratocystic Odontogenic Tumor. </a></div><br /><div class="p4l_captionBody"><b>The protein expression of SHH pathway components was down-regulated by cyclopamine treatment.</b> KCOT-1 cells were treated with cyclopamine (C) (10, 20, and 25 μm) or tomatidine (T) (5 and 10 μm) or no treatment (NT) for 48 h. A, protein expression for the SHH pathway. B, densitometric analysis of the calculated reduction of the protein levels of the SHH signaling pathway. OD Ratio, optical density ratio.</div></div>